an injectable form of ARSENIC called Trisenox
November 2000
Oncologists are now using an injectable form of ARSENIC called Trisenox.
Trisenox (arsenic trioxide) is for second-line therapy of acute promyelocytic leukemia.
It's very effective...up to 70% remission in patients who don't do well on standard chemotherapy.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive